内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Magrath George. Officer active across 2 companies, notably Ocuphire Pharma, Inc.. In total, 15 filings have been published. Split: 4 buys · 3 sells. Total volume traded: €412k. Activity tracked since 1 November 2023. The latest transaction was disclosed on 23 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Magrath George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
9,475 股@ US$2.9473Common StockSEC:0000905148-26-003352:0
9,511 股@ US$5.220.0027% mcap16.1% 占其流量Common StockSEC:0000905148-26-001864:0
24,438 股@ US$5.210229.7% 占其流量Common StockSEC:0000905148-26-001381:0
483,639 股0Common StockSEC:0000905148-26-000356:0
30,350 股@ US$2.3012.2% 占其流量Common StockSEC:0000905148-25-003777:0
30,350 股@ US$2.3013.9% 占其流量Common StockSEC:0000905148-25-003767:0
392,157 股Common StockSEC:0000905148-25-001007:0
330,697 股0Common StockSEC:0000905148-25-000940:0
100,000 股@ US$0.97642.5% 占其流量Common StockSEC:0000905148-24-003425:0
6,200 股0Common StockSEC:0000905148-24-003406:0
90,294 股@ US$1.010239.3% 占其流量Common StockSEC:0000905148-24-003236:0
37,050 股@ US$1.1818.2% 占其流量Common StockSEC:0000905148-24-002934:0
5,000 股@ US$1.754515.2% 占其流量Common StockSEC:0000905148-24-001568:0
25,000 股@ US$1.96284.8% 占其流量Common StockSEC:0000905148-24-000991:0
400,000 股0Common StockSEC:0001140361-23-051320:0
About Magrath George
Magrath George is Chief Executive Officer of Opus Genetics, Inc. and Ocuphire Pharma, Inc. The record shows 9 filings in total, and across the 9 sampled recent filings there were buy transactions totaling 233618 EUR and no sell transactions, with activity dated from 2023-11-03 to 2025-03-26; the modal transaction nature is Attribution.